BioGaia Announces Interim Report

- Net sales amounted to SEK 151.2 million (106.0), an increase of SEK 45.2 million (43%).

- Operating profit was SEK 36.4 million (18.4), an increase of SEK 18 million.

- Profit before tax was SEK 42.6 million (20.1), an increase of SEK 22.5 million.

- Due to the earlier cumulative loss carry forward, BioGaia pays no tax. Profit after reported tax was SEK 29.3 million (31.1), a decrease of SEK 1.8 million. The period's reported tax expense of SEK 13.3 million refers to a change in the deferred tax asset. Profit for the corresponding period of last year included a deferred tax benefit of SEK 11.0 million.

- Earnings per share after reported tax amounted to SEK 1.70 (1.81).

- The period's cash flow from operating activities before change in working capital was SEK 40.0 million (23.3). Total cash flow for the period was SEK 29.7 million (15.7). Cash and cash equivalents at 30 September 2009 amounted to SEK 87.5 million.

Third quarter 1 July - 30 September 2009

- Net sales for the third quarter amounted to SEK 38.7 million (33.6), an increase of SEK 5.1 million (15%) over the same period of last year. Including early deliveries from the second quarter, sales rose by 31%.

- Operating profit was SEK 6.4 million (5.8), an increase of SEK 0.6 million.

- Profit before tax was SEK 11.3 million (6.5), an increase of SEK 4.8 million.

- Due to the earlier cumulative loss carry forward, BioGaia pays no tax. Profit after reported tax was SEK 7.7 million (9.0), a decrease of SEK 1.3 million. The period's reported tax expense of SEK 3.6 million refers to a change in the deferred tax asset. Profit for the corresponding period of last year included a deferred tax benefit of SEK 2.5 million.

Key events in the third quarter of 2009

- Agreement with Laboratoires BIOETHIC for the sale of BioGaia's Probiotic tablets and drops in France.

Key events after the end of the reporting period

- Agreement with Pharma Nord for the sale of BioGaia's Probiotic tablets and drops in Denmark.

"We are continuing to see very satisfactory growth with sustained gross margins and a strong cash flow. In the first three quarters of the year our sales rose by 43%, a trend that reflects the rising demand we are noting in various markets and the pace of our product launches. It is also satisfying that the BioGaia brand accounted for a full 32% of our sales of finished consumer products, which is the result of a deliberate focus on developing our own brand." says Managing Director Peter Rothschild.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish